title: [Primary penile tuberculosis].
authors.affiliation: Dermatologie A, CHU Ibn Sina, université Mohammed V Souissi, avenue Ahmed-Balafrej, 10000 Rabat, Maroc. Electronic address: raffaswafae@hotmail.fr.
authors.forename: W
authors.initials: W
authors.lastname: Raffas
authors.forename: F
authors.initials: F
authors.lastname: El Amrani
authors.forename: F
authors.initials: F
authors.lastname: Tbatou
authors.forename: F
authors.initials: F
authors.lastname: Khalil
authors.forename: A
authors.initials: A
authors.lastname: Benzekri
authors.forename: B
authors.initials: B
authors.lastname: Hassam
authors.forename: L
authors.initials: L
authors.lastname: Benzekri
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010409:Penile Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012883:Skin Ulcer / Q000209:etiology; D014389:Tuberculosis, Male Genital / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014820:Vitiligo / Q000150:complications
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin